Current strategies and novel immunotherapeutic approaches for overcoming immune resistance in glioblastoma

Abstract Glioblastoma (GBM) is the most aggressive primary malignant brain tumor, characterized by rapid proliferation, extensive invasion, and significant genetic heterogeneity. Despite the availability of standard treatments such as surgical resection, radiotherapy, and chemotherapy, the prognosis...

詳細記述

書誌詳細

主要な著者:	Mehrdad Nourizadeh, Saeid Mohammadzadeh Mounesyar, Mahdi Salimi Movahhed, Kasra Alipour, Rozhan Zekavatbakhsh, Mobina Hoseinzadeh, Shaghayegh Davari, Mehdi Amirhooshangi, Hadi Amirhoushangi, Sina Hamzehzadeh
フォーマット:	Artigo
言語:	Inglês
出版事項:	Springer 2025-10-01
シリーズ:	Discover Oncology
主題:	Glioblastoma Immunotherapy Gene editing Nanoparticles CAR-T Exosomes
オンライン･アクセス:	https://doi.org/10.1007/s12672-025-03807-2
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!